Modified Clostridial toxins comprising an integrated protease cleavage sitebinding domain

Details for Australian Patent Application No. 2010353292 (hide)

Owner Allergan, Inc.

Inventors Ghanshani, Sanjiv; Le, Linh Q.; Liu, Yi; Steward, Lance E.

Agent Davies Collison Cave

Pub. Number AU-A-2010353292

PCT Pub. Number WO2011/142783

Priority 61/286,954 16.12.09 US

Filing date 14 December 2010

Wipo publication date 17 November 2011

International Classifications

A61K 38/48 Medicinal preparations containing peptides

A61K 8/66 Cosmetics or similar toilet preparations

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61Q 19/08 Preparations for care of the skin - Anti-ageing preparations

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 9/52 Enzymes, e.g. ligases (6.) - derived from bacteria

C12N 15/63 Mutation or genetic engineering - Introduction of foreign genetic material using vectors

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/142783 Priority application(s): WO2011/142783

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010353294-Flame-resistant composite materials and articles containing carbon nanotube-infused fiber materials

2010353271-Device for heating process water